Nelson Neal Stone MD

Dr. Nelson Stone is an internationally renowned prostate cancer specialist, academician, innovator, and entrepreneur. In 1995, he created the real-time 3D Brachytherapy System, PROSEED, which was acquired by CR Bard in 1998. Dr. Stone served as VP and Medical Director at Bard, which, under his direction, trained over 200 centers in the U.S. and Europe. In 2005, Dr. Stone and his partners started Prologics, a radiation therapy services company. This company was successfully sold to Integrated Oncology Network in 2011. In 2012, he co-founded 3DBiopsy, Inc., which developed innovative biopsy and pathology technology. Named as one of the "Leading Physicians of the World", Dr. Stone is a Professor of Urology and Radiation Oncology at the Icahn School of Medicine at Mount Sinai, NYC. Dr. Stone earned his M.D. from the University of Maryland and attended fellowships in urologic oncology at Memorial Sloan Kettering Cancer Center and biomedical endocrinology at Rockefeller University. He joined VIOMERSE in 2021.